Markets
BSX

Health Care Sector Update for 03/05/2018: DERM, ZYNE, AIMT, BSX

A generic image of a pen and a calculator
Credit: Shutterstock photo

Top Health care stocks:

JNJ: flat

PFE: flat

ABT: flat

MRK: flat

AMGN: flat

Health care shares were steady ahead of the bell on Monday.

Expected movers:

- Dermira ( DERM ): halted as two phase 3 trials in acne vulgaris fail to meet co-primary endpoints

- Zynerba Pharmaceuticals ( ZYNE ): to launch pivotal study to support NDA for genetic disease drug

- Aimmune ( AIMT ): says phase 3 trial of AR101 in peanut allergy meets primary, secondary endpoints

Other news:

- Boston Scientific ( BSX ): acquires medical device manufacturer EMcision

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Copyright (C) 2016 MTNewswires.com. All rights reserved. Unauthorized reproduction is strictly prohibited.


The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

In This Story

BSX ZYNE AIMT

Other Topics

US Markets

Latest Markets Videos

    MTNewswires

    Founded in 1999, MT Newswires (formerly known as Midnight Trader) is a leading provider of original source, multi-asset class, real-time, global financial news and information to most of the largest banks, brokerage firms and professional market data, trading & research applications in North America.

    Learn More